share_log

Avrobio Analyst Ratings

Avrobio Analyst Ratings

Avrobio 分析師評級
Benzinga ·  2023/07/13 19:53
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/13/2023 39.86% Wells Fargo $2.5 → $2 Maintains Overweight
07/12/2023 39.86% Wedbush → $2 Downgrades Outperform → Neutral
03/24/2023 249.65% Mizuho $6 → $5 Maintains Buy
03/24/2023 319.58% Needham → $6 Reiterates → Buy
12/08/2022 179.72% BTIG → $4 Upgrades Neutral → Buy
05/17/2022 319.58% Needham $8 → $6 Maintains Buy
05/11/2022 179.72% Barclays $6 → $4 Maintains Overweight
01/06/2022 319.58% Mizuho $28 → $6 Maintains Buy
01/05/2022 319.58% Barclays $22 → $6 Maintains Overweight
01/05/2022 109.79% Morgan Stanley $7 → $3 Maintains Equal-Weight
01/05/2022 BTIG Downgrades Buy → Neutral
01/05/2022 459.44% Needham $28 → $8 Maintains Buy
11/19/2021 389.51% Morgan Stanley $24 → $7 Downgrades Overweight → Equal-Weight
10/12/2021 1648.25% Morgan Stanley $27 → $25 Maintains Overweight
07/16/2021 1927.97% Morgan Stanley $31 → $29 Maintains Overweight
06/15/2021 1508.39% BTIG → $23 Initiates Coverage On → Buy
05/27/2021 1858.04% Needham → $28 Maintains Buy
05/14/2021 2067.83% Morgan Stanley $34 → $31 Maintains Overweight
05/03/2021 599.3% SVB Leerink $18 → $10 Maintains Market Perform
03/09/2021 1508.39% Barclays → $23 Initiates Coverage On → Overweight
03/02/2021 879.02% Stifel → $14 Initiates Coverage On → Hold
11/11/2020 1788.11% Berenberg → $27 Initiates Coverage On → Buy
10/13/2020 2277.62% Morgan Stanley $35 → $34 Maintains Overweight
07/15/2020 2347.55% Morgan Stanley $37 → $35 Maintains Overweight
03/31/2020 2487.41% Morgan Stanley $40 → $37 Maintains Overweight
03/31/2020 809.09% HC Wainwright & Co. $35 → $13 Downgrades Buy → Neutral
03/31/2020 HC Wainwright & Co. Downgrades Buy → Neutral
02/12/2020 2697.2% Morgan Stanley $37 → $40 Maintains Overweight
11/11/2019 2137.76% Wedbush $43 → $32 Maintains Outperform
10/28/2019 2347.55% Nomura → $35 Initiates Coverage On → Buy
06/27/2019 1858.04% Mizuho → $28 Initiates Coverage On → Buy
04/05/2019 Janney Montgomery Scott Initiates Coverage On → Buy
11/28/2018 1788.11% Leerink Swann → $27 Initiates Coverage On → Market Perform
09/17/2018 3186.71% HC Wainwright & Co. → $47 Initiates Coverage On → Buy
08/13/2018 2697.2% Morgan Stanley $37 → $40 Maintains Overweight
07/16/2018 2697.2% Wells Fargo → $40 Initiates Coverage On → Outperform
07/16/2018 Cowen & Co. Initiates Coverage On → Outperform
07/16/2018 2557.34% Wedbush → $38 Initiates Coverage On → Outperform
07/16/2018 2487.41% Morgan Stanley → $37 Initiates Coverage On → Overweight
日期 上行/下行 分析公司 目標價格變化 評級變化 上一次/當前評級
07/13/2023 39.86% 富國銀行 $2.5→$2 維護 超重
07/12/2023 39.86% 韋德布什 →$2 評級下調 跑贏→中性
03/24/2023 249.65% 瑞穗 $6→$5 維護
03/24/2023 319.58% 李約瑟 →$6 重申 →購買
12/08/2022 179.72% BTIG →$4 升級 中性→購買
2022/05/17 319.58% 李約瑟 $8→$6 維護
2022年05月11日 179.72% 巴克萊 $6→$4 維護 超重
01/06/2022 319.58% 瑞穗 $28→$6 維護
01/05/2022 319.58% 巴克萊 $22→$6 維護 超重
01/05/2022 109.79% 摩根士丹利 $7→$3 維護 等重
01/05/2022 - BTIG 評級下調 購買→中性
01/05/2022 459.44% 李約瑟 $28→$8 維護
2021年11月19日 389.51% 摩根士丹利 $24→$7 評級下調 超重→等重
10/12/2021 1648.25% 摩根士丹利 $27→$25 維護 超重
07/16/2021 1927.97% 摩根士丹利 $31→$29 維護 超重
2021/06/15 1508.39% BTIG →$23 開始承保 →購買
2021/05/27 1858.04% 李約瑟 →$28 維護
2021/05/14 2067.83% 摩根士丹利 $34→$31 維護 超重
05/03/2021 599.3% SVB Leerink $18→$10 維護 市場表現
03/09/2021 1508.39% 巴克萊 →$23 開始承保 →超重
03/02/2021 879.02% Stifel →$14 開始承保 →保留
11/11/2020 1788.11% 貝倫伯格 →$27 開始承保 →購買
10/13/2020 2277.62% 摩根士丹利 $35→$34 維護 超重
07/15/2020 2347.55% 摩根士丹利 $37→$35 維護 超重
03/31/2020 2487.41% 摩根士丹利 $40→$37 維護 超重
03/31/2020 809.09% HC Wainwright公司 $35→$13 評級下調 購買→中性
03/31/2020 - HC Wainwright公司 評級下調 購買→中性
02/12/2020 2697.2% 摩根士丹利 $37→$40 維護 超重
2019年11月11日 2137.76% 韋德布什 $43→$32 維護 跑贏大盤
2019年10月28日 2347.55% 野村 →$35 開始承保 →購買
2019年06月27日 1858.04% 瑞穗 →$28 開始承保 →購買
2019年05月04日 - 詹尼·蒙哥馬利·斯科特 開始承保 →購買
2018年11月28日 1788.11% 利林克·斯旺 →$27 開始承保 →市場表現
2018年09月17日 3186.71% HC Wainwright公司 →$47 開始承保 →購買
2018年08月13日 2697.2% 摩根士丹利 $37→$40 維護 超重
2018年07月16日 2697.2% 富國銀行 →$40 開始承保 →跑贏大盤
2018年07月16日 - 考恩公司 開始承保 →跑贏大盤
2018年07月16日 2557.34% 韋德布什 →$38 開始承保 →跑贏大盤
2018年07月16日 2487.41% 摩根士丹利 →$37 開始承保 →超重

What is the target price for Avrobio (AVRO)?

Avrobio(Avro)的目標價是多少?

The latest price target for Avrobio (NASDAQ: AVRO) was reported by Wells Fargo on July 13, 2023. The analyst firm set a price target for $2.00 expecting AVRO to rise to within 12 months (a possible 39.86% upside). 5 analyst firms have reported ratings in the last year.

富國銀行於2023年7月13日報道了Avrobio(納斯達克:AVRO)的最新目標價。這家分析公司將目標價定為2.00美元,預計Avro將在12個月內上漲(可能上漲39.86%)。去年有5家分析公司公佈了評級。

What is the most recent analyst rating for Avrobio (AVRO)?

Avrobio(Avro)的最新分析師評級是多少?

The latest analyst rating for Avrobio (NASDAQ: AVRO) was provided by Wells Fargo, and Avrobio maintained their overweight rating.

富國銀行對Avrobio(納斯達克代碼:AVRO)的最新分析師評級維持其增持評級。

When is the next analyst rating going to be posted or updated for Avrobio (AVRO)?

Avrobio(Avro)的下一次分析師評級將於何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Avrobio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Avrobio was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.

分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公開財務報表,與Avrobio的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Avrobio的上一次評級是在2023年7月13日提交的,所以你應該預計下一次評級將在2024年7月13日左右的某個時候公佈。

Is the Analyst Rating Avrobio (AVRO) correct?

分析師對Avrobio(Avro)的評級正確嗎?

While ratings are subjective and will change, the latest Avrobio (AVRO) rating was a maintained with a price target of $2.50 to $2.00. The current price Avrobio (AVRO) is trading at is $1.43, which is out of the analyst's predicted range.

雖然評級是主觀的,並將發生變化,但Avrobio(Avro)的最新評級保持不變,目標價在2.50美元至2.00美元之間。Avrobio(Avro)目前的交易價格為1.43美元,超出了分析師的預測區間。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論